Data related to the chemical part of the project: spectroscopic and spectrometric data for the structural elucidation of the molecules, as well as the spectrometric data of ceramide-type biomarkers
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The dataset generated in this project consists of the spectra necessary for the structural elucidation of the synthesized molecules and ceramide-type molecules as biomarkers. It includes raw data and processed data for visualization. 1) NMR Spectra: Nuclear Magnetic Resonance (NMR) data. Includes: ¹H, ¹³C, DEPT, COSY, HSQC, HMBC, and other 2D experiments used in structural characterization. Formats: native spectrometer formats (Bruker/Varian directories), and/or processed data: FID files exported for analysis. Content: spectral signals, acquisition parameters, and instrumental metadata. 2) LC-MS Spectra: ESI-MS: raw data in .lcd format (Shimadzu), including complete spectra, relative intensities, instrumental parameters, and metadata. 3) LC-MS_Cer Spectra: UHPLC-mass spectrometry (MS) data relating to ceramides in mouse plasma. ESI-MS: Primary data in .lcd (Shimadzu) format, including full spectra, relative intensities, instrumental parameters, and metadata.
Fields of Study & Subjects
Sphingolipid Metabolism and Signaling
Metabolomics and Mass Spectrometry Studies
Mass Spectrometry Techniques and Applications
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 30 March 2026
- Language
- EN
- Document type
- Dataset